Cas:1559-36-0 diethylene glycol mono2-ethylhexyl ether manufacturer & supplier

Chemical Name:diethylene glycol mono2-ethylhexyl ether

CAS.NO:1559-36-0

Synonyms:di(ethylene glycol) 2-ethylhexyl ether;diethylene glycol mono 2-ethylhexyl ether;diethylene glycol mono-2-ethyl hexyl ether (kyowanol ox20);2-ethylhexyl diglycol;2-[2-[(2-ethylhexyl)oxy]ethoxy]ethanol;2-{2-[(2-ethylhexyl)oxy]ethoxy}ethanol

Molecular Formula:C₁₂H₂₆O₃

Molecular Weight:218.33300

HS Code:2909499000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:38.69000

Exact Mass:218.18800

LogP:2.22830

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like di(ethylene glycol) 2-ethylhexyl ether chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-{2-[(2-ethylhexyl)oxy]ethoxy}ethanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,diethylene glycol mono-2-ethyl hexyl ether (kyowanol ox20) Use and application,2-ethylhexyl diglycol technical grade,usp/ep/jp grade.

Related News: One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. diethylene glycol mono2-ethylhexyl ether manufacturer The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. diethylene glycol mono2-ethylhexyl ether supplier ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. diethylene glycol mono2-ethylhexyl ether vendor As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics. diethylene glycol mono2-ethylhexyl ether factory As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics.